Avatrombopag isn't going to contend with TPO for binding on the TPO receptor and it has an additive effect with TPO on platelet creation. 5.1 Thrombotic/Thromboembolic Complications DOPTELET is a thrombopoietin (TPO) receptor agonist and TPO receptor agonists are already related to thrombotic and thromboembolic troubles in patients with Persistent https://archervdimp.thechapblog.com/22261384/blu-782-options